With the proceeds, Visionary Venture Fund expects to invest up to $30m in approximately a dozen of promising ophthalmology companies over the next 18 months.
Led by Managing Partner Jeffry Weinhuff, CEO of OCTANe Bill Carpou and partners Dr. Richard Lindstrom, Dr. Eric Donnenfeld and Dr. Kerry Solomon, Visionary Venture Fund is an ophthalmology focused venture capital firm.
Backed companies include:
– IanTech, an organization working on a minimally invasive micro-interventional device to treat cataracts in a safe and cost-effective manner.
– Mynosys, a group developing a device that uses precision pulse technology to create an accurate and reproducible capsulotomy, and
– SightLife Surgical, an eye bank and specialist in providing corneal tissue and services to cornea surgeons.